Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECARD LD&HD Combination Tablets Long-term Special Drug Use Surveillance
jRCT1080222313
- Sponsor
- Takeda
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of candesartan cilexetil + hydrochlorothiazide in hypertension (HTN), sponsored by Takeda.
02
Drugs
candesartan cilexetil + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on jRCT1080222313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222313.